Burden, effectiveness and safety of influenza vaccines in elderly, paediatric and pregnant populations

Therapeutic Advances in Vaccines and Immunotherapy
Sheena G SullivanAnnette K Regan

Abstract

Vaccination is the most practical means available for preventing influenza. Influenza vaccines require frequent updates to keep pace with antigenic drift of the virus, and the effectiveness, and sometimes the safety, of the vaccine can therefore vary from season to season. Three key populations that the World Health Organization recommends should be prioritized for influenza vaccination are pregnant women, children younger than 5 years of age and the elderly. This review discusses the burden of influenza and the safety and effectiveness profile of influenza vaccines recommended for these groups.

References

May 19, 1984·British Medical Journal·A L WilliamsL Bretherton
May 1, 1982·American Journal of Epidemiology·I M LonginiJ P Fox
Jan 29, 2000·The New England Journal of Medicine·K M NeuzilM R Griffin
May 11, 2000·The New England Journal of Medicine·S F DowellD K Shay
Nov 30, 2000·Current Infectious Disease Reports·K M Neuzil
Apr 2, 2004·Pediatrics International : Official Journal of the Japan Pediatric Society·Taro MaedaYoshiyasu Yamada
May 13, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Laura Jean PodewilsUNKNOWN Infectious Diseases Society of America Emerging Infections Network
Jun 21, 2005·Journal of Epidemiology and Community Health·Douglas M FlemingKenneth W Cross
Dec 16, 2005·The New England Journal of Medicine·Niranjan BhatUNKNOWN Influenza Special Investigations Team
Mar 7, 2006·PLoS Medicine·Chit Ming WongJoseph S M Peiris
Mar 24, 2006·The New England Journal of Medicine·Johannes C van der WoudenSiep Thomas
May 24, 2006·Archives of Internal Medicine·Wendy A KeitelRobert B Couch
Jul 11, 2006·The New England Journal of Medicine·Katherine A PoehlingUNKNOWN New Vaccine Surveillance Network
Oct 26, 2006·JAMA : the Journal of the American Medical Association·Simon J HambidgeUNKNOWN Vaccine Safety Datalink Team
Nov 1, 2006·Vaccine·John P MulloolyUNKNOWN Vaccine Safety Datalink Adult Working Group
Dec 13, 2006·Epidemiology and Infection·C G GrijalvaM R Griffin
Feb 14, 2007·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Linda DoddsNoni MacDonald
Feb 16, 2007·The New England Journal of Medicine·Robert B BelsheUNKNOWN CAIV-T Comparative Efficacy Study Group
Dec 7, 2007·Health Policy·Emmanuelle SavidanGrenville Marsh
Sep 19, 2008·The New England Journal of Medicine·K ZamanMark C Steinhoff
May 16, 2009·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J GaillatF Carrat
Aug 18, 2009·Journal of the American Geriatrics Society·Magali LemaitreFabrice Carrat
Dec 17, 2009·Vaccine·Ian G BarrUNKNOWN Writing Committee of the World Health Organization Consultation on Northern Hemisphere Influenza Vaccine Composition for 200
Dec 19, 2009·Lancet·Heath Kelly, Ian Barr
Apr 30, 2010·The New England Journal of Medicine·Mark C SteinhoffKhalequ Zaman M B B S
Jul 14, 2010·Forensic Science, Medicine, and Pathology·M A WeberN J Sebire
Nov 10, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Isaac BenowitzMarietta Vázquez
Feb 11, 2011·Influenza and Other Respiratory Viruses·Christopher S AmbroseRobert B Belshe
May 24, 2011·American Journal of Epidemiology·Dena SchanzerLouise Pelletier

❮ Previous
Next ❯

Citations

May 8, 2019·The Medical Journal of Australia·Frank H BeardKristine Macartney
May 23, 2019·Expert Review of Vaccines·Kylie E C AinslieWalt A Orenstein
Jan 9, 2020·European Journal of Pediatrics·Kirsten MaertensElke Leuridan
Jan 11, 2020·Frontiers in Immunology·Elena V VassilievaRichard W Compans
May 21, 2021·BMC Infectious Diseases·Chan-Wa CheongCheng-Yu Chien
Aug 24, 2021·Infectious Diseases and Therapy·Juan Miguel PascalePatricia Juliao
Sep 30, 2021·European Journal of Medical Research·Gbadebo Collins AdeyanjuCornelia Betsch

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.